The bad news continues for the novel strategy of immunizing people against Alzheimer’s disease. Elan Corp. of Dublin now acknowledges that 15 people developed potentially dangerous brain inflammation after receiving vaccinations designed to clear their brains of the protein deposits thought to cause Alzheimer’s disease. The patients, who already had mild to moderate Alzheimer’s disease, are recovering under physicians’ care, the company says.
Log in
Subscribers, enter your e-mail address for full access to the Science News archives and digital editions.